Matthew J. Feinstein

3.7k total citations · 2 hit papers
101 papers, 2.1k citations indexed

About

Matthew J. Feinstein is a scholar working on Emergency Medicine, Cardiology and Cardiovascular Medicine and Surgery. According to data from OpenAlex, Matthew J. Feinstein has authored 101 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Emergency Medicine, 40 papers in Cardiology and Cardiovascular Medicine and 28 papers in Surgery. Recurrent topics in Matthew J. Feinstein's work include HIV-related health complications and treatments (44 papers), Lipoproteins and Cardiovascular Health (19 papers) and Viral Infections and Immunology Research (13 papers). Matthew J. Feinstein is often cited by papers focused on HIV-related health complications and treatments (44 papers), Lipoproteins and Cardiovascular Health (19 papers) and Viral Infections and Immunology Research (13 papers). Matthew J. Feinstein collaborates with scholars based in United States, Canada and Philippines. Matthew J. Feinstein's co-authors include Donald M. Lloyd‐Jones, Priscilla Y. Hsue, Matthew S. Freiberg, Chad J. Achenbach, Gerald S. Bloomfield, Laura Benjamin, Kaku So‐Armah, Arjun Sinha, Chris T. Longenecker and Wendy S. Post and has published in prestigious journals such as Circulation, The Journal of Experimental Medicine and Journal of the American College of Cardiology.

In The Last Decade

Matthew J. Feinstein

93 papers receiving 2.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Characteristics, Prevention, and Management of Cardiovascular Disease in People Living With HIV: A Scientific Statement From the American Heart Association

2019 384 citations Matthew J. Feinstein, Priscilla Y. Hsue et al. Circulation profile →
HIV and cardiovascular disease

2020 167 citations Kaku So‐Armah, Laura Benjamin et al. The Lancet HIV profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Matthew J. Feinstein United States	22	1.1k	713	538	474	349	101	2.1k
David A. Zidar United States	19	378 0.3×	541 0.8×	1.3k 2.4×	262 0.6×	311 0.9×	59	2.9k
Virginia A. Triant United States	28	3.3k 3.0×	674 0.9×	1.9k 3.5×	684 1.4×	726 2.1×	76	4.2k
Federica Carli Italy	21	1.6k 1.4×	149 0.2×	1.1k 2.1×	114 0.2×	644 1.8×	42	2.2k
Alinda G. Vos Netherlands	14	528 0.5×	163 0.2×	486 0.9×	178 0.4×	195 0.6×	43	1.5k
Zhigang Lu China	27	127 0.1×	600 0.8×	1.1k 2.0×	549 1.2×	619 1.8×	108	3.0k
Kimberly W. Hart United States	24	416 0.4×	213 0.3×	161 0.3×	136 0.3×	475 1.4×	91	1.5k
Deven Patel United Kingdom	20	212 0.2×	545 0.8×	353 0.7×	221 0.5×	176 0.5×	39	1.4k
Giuseppe Fiorentino Italy	19	215 0.2×	128 0.2×	427 0.8×	108 0.2×	131 0.4×	112	1.4k
Lisa Rosenblatt United States	24	122 0.1×	549 0.8×	200 0.4×	82 0.2×	214 0.6×	111	1.6k
Kenneth Strauss United States	24	317 0.3×	54 0.1×	188 0.3×	163 0.3×	169 0.5×	57	2.1k

Countries citing papers authored by Matthew J. Feinstein

Since Specialization

Citations

This map shows the geographic impact of Matthew J. Feinstein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew J. Feinstein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew J. Feinstein more than expected).

Fields of papers citing papers by Matthew J. Feinstein

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthew J. Feinstein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew J. Feinstein. The network helps show where Matthew J. Feinstein may publish in the future.

Co-authorship network of co-authors of Matthew J. Feinstein

This figure shows the co-authorship network connecting the top 25 collaborators of Matthew J. Feinstein. A scholar is included among the top collaborators of Matthew J. Feinstein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthew J. Feinstein. Matthew J. Feinstein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Beydoun, Nour, Matthew S. Durstenfeld, Bridget M. Whitney, et al.. (2025). Multicenter study of heart failure phenotypes and physician-adjudicated causes in people with HIV. AIDS. 39(9). 1246–1253.

Thorp, Edward B., et al.. (2024). CCR2+ monocytes promote white matter injury and cognitive dysfunction after myocardial infarction. Brain Behavior and Immunity. 119. 818–835. 6 indexed citations

Wilkins, John, Hongyan Ning, Norrina B. Allen, et al.. (2024). Prediction of Cumulative Exposure to Atherogenic Lipids During Early Adulthood. Journal of the American College of Cardiology. 84(11). 961–973. 9 indexed citations

Rivera, Adovich S., et al.. (2024). Association of early statin initiation during COVID-19 admission with inpatient mortality at an academic health system in Illinois, March 2020 to September 2022: a target trial emulation using observational data. BMJ Open. 14(10). e085547–e085547. 1 indexed citations

Chen, Chunlei, Jason Shapiro, Hsiang‐Chun Chang, et al.. (2024). Human induced pluripotent stem cell-derived cardiomyocytes to study inflammation-induced aberrant calcium transient. eLife. 13. 1 indexed citations

Gao, Jing, Joseph A. Delaney, Laura J. Rasmussen‐Torvik, et al.. (2024). Immune Cell Profiling of the ICAM1 p.K56M Heart Failure with Preserved Ejection Fraction Risk Variant. ESC Heart Failure. 11(6). 4427–4431. 1 indexed citations

Dalal, Prarthana, Abigail S. Baldridge, Arjun Sinha, et al.. (2023). Myocardial strain is associated with adverse cardiac events in patients treated with chimeric antigen receptor (CAR) T‐cell therapy. European Journal Of Haematology. 112(1). 102–110. 10 indexed citations

Saleh, Danish, et al.. (2023). Emerging Roles for Dendritic Cells in Heart Failure. Biomolecules. 13(10). 1535–1535. 4 indexed citations

Dalal, Prarthana, et al.. (2022). Adverse Cardiac Effects of CAR T-Cell Therapy: Characteristics, Surveillance, Management, and Future Research Directions. Technology in Cancer Research & Treatment. 21. 2213874815–2213874815. 12 indexed citations

10.

Dalal, Prarthana, et al.. (2021). Abstract 14343: Predictive Value of Myocardial Strain for Chimeric Antigen Receptor T-cell Therapy Associated Cardiovascular Events. Circulation. 144(Suppl_1). 1 indexed citations

11.

Feinstein, Matthew J., Chad J. Achenbach, Raymond R. Townsend, et al.. (2021). Antihypertensive Class and Cardiovascular Outcomes in Patients With HIV and Hypertension. Hypertension. 77(6). 2023–2033. 9 indexed citations

12.

Dalal, Prarthana, et al.. (2021). Abstract 14394: Cardiovascular Toxicities After Chimeric Antigen Receptor T-cell (CAR-T) Therapy: A Single Center Experience. Circulation. 144(Suppl_1). 1 indexed citations

13.

DeBerge, Matthew, Arjun Sinha, Jiao-Jing Wang, et al.. (2021). Bone marrow-derived AXL tyrosine kinase promotes mitogenic crosstalk and cardiac allograft vasculopathy. The Journal of Heart and Lung Transplantation. 40(6). 435–446. 6 indexed citations

14.

So‐Armah, Kaku, Laura Benjamin, Gerald S. Bloomfield, et al.. (2020). HIV and cardiovascular disease. The Lancet HIV. 7(4). e279–e293. 167 indexed citations breakdown →

15.

Feinstein, Matthew J., Priscilla Y. Hsue, Laura Benjamin, et al.. (2019). Characteristics, Prevention, and Management of Cardiovascular Disease in People Living With HIV: A Scientific Statement From the American Heart Association. Circulation. 140(2). e98–e124. 384 indexed citations breakdown →

16.

Nance, Robin M., Heidi M. Crane, Corey Ritchings, et al.. (2018). Differentiation of Type 1 and Type 2 Myocardial Infarctions Among HIV-Infected Patients Requires Adjudication Due to Overlap in Risk Factors. AIDS Research and Human Retroviruses. 34(11). 916–921. 3 indexed citations

17.

Feinstein, Matthew J., June‐Ho Kim, Jeffrey N. Martin, et al.. (2016). Ideal Cardiovascular Health and Carotid Atherosclerosis in a Mixed Cohort of HIV-Infected and Uninfected Ugandans. AIDS Research and Human Retroviruses. 33(1). 49–56. 34 indexed citations

18.

Feinstein, Matthew J. & Donald M. Lloyd‐Jones. (2016). Monoclonal Antibodies for Lipid Management. Current Atherosclerosis Reports. 18(7). 39–39. 6 indexed citations

19.

Feinstein, Matthew J., Pardeep S. Jhund, Joseph Kang, et al.. (2015). Do Statins Reduce the risk of Myocardial Infarction in Patients with Heart Failure? A Pooled Individual-Level Reanalysis of CORONA and GISSI-HF. European Journal of Heart Failure. 17(4). 434–441. 31 indexed citations

20.

Feinstein, Matthew J. & Laurence A. Rubin. (1978). The foot and Apert's syndrome: acrocephalosyndactyly. Journal of the American Podiatric Medical Association. 68(11). 748–753. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact